Sponsor:
Cincinnati Eye Institute, Southwest Ohio
Code:
NCT06541574
Conditions
Proliferative Vitreoretinopathy
Rhegmatogenous Retinal Detachment
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Methotrexate Injection
Methotrexate Infusion
Sham Injection
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-24. This information was provided to ClinicalTrials.gov by Cincinnati Eye Institute, Southwest Ohio on 2024-09-19.